Identification of novel blood biomarkers of treatment response in cystic fibrosis pulmonary exacerbations by label-free quantitative proteomics

Pulmonary exacerbations (PEx) are clinically impactful events for individuals with CF. Unfortunately, many CF individuals with PEx fail to regain their baseline lung function despite treatment. The objective of this study was to use unbiased proteomic technology to identify novel blood protein bioma...

Descripción completa

Detalles Bibliográficos
Autores principales: Dong, Kang, Moon, Kyung-Mee, Chen, Virginia, Ng, Raymond, Foster, Leonard J., Tebbutt, Scott J., Quon, Bradley S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2019
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6868239/
https://www.ncbi.nlm.nih.gov/pubmed/31748618
http://dx.doi.org/10.1038/s41598-019-53759-1

Ejemplares similares

Ejemplares similares